Evidence summaries and landmark trials across type 1, type 2, prevention, glycaemic control, complications, and diabetes technology.
A small 4-week RCT finds L-citrulline 6 g/day improves endothelial function, leg arterial stiffness, and glucose in type 2 diabetes, in both fasted and acute-hyperglycaemic states. PICO summary and commentary.
A 12-week RCT finds both combined training and HIIT improve glucose, body composition, and quality of life in type 2 diabetes, with HIIT favouring fasting glucose and combined training favouring insulin resistance and wellbeing. PICO summary and commentary.
A small crossover validation study finds the Vyntus CPX metabolic cart gives indirect-calorimetry measurements comparable to the Vmax Encore 29N in type 2 diabetes, with only minor differences. PICO summary and commentary.
A secondary analysis finds women with gestational diabetes reach similar BMI to unaffected women by 3 years postpartum, but their children are twice as likely to be overweight despite comparable diets. PICO summary and commentary.
A 7-month crossover trial finds a dietary phytomix (Dibifree) reduces HbA1c and glucose and body fat in type 2 diabetes, with effects sustained after washout, though the study was biotech-affiliated. PICO summary and commentary.
A feasibility pilot finds remote walking coaching is acceptable and mitigates late-pregnancy activity decline in pregnancy hyperglycaemia, with only a preliminary suggestion of neonatal benefit. PICO summary and commentary.
A pilot study finds a computer-vision food-photo app estimates energy intake about as well as 24-hour recall, but both underestimate true intake versus measured expenditure. PICO summary and commentary.
Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.
© 2024-2026 Hormone Insight. All rights reserved.
